Page last updated: 2024-09-05

sorafenib and acacetin

sorafenib has been researched along with acacetin in 2 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(acacetin)
Trials
(acacetin)
Recent Studies (post-2010) (acacetin)
6,5207305,2512311159

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)acacetin (IC50)
Cytochrome P450 1A1Homo sapiens (human)0.083
Cytochrome P450 1A2Homo sapiens (human)0.1655
Amine oxidase [flavin-containing] AHomo sapiens (human)0.167
Potassium voltage-gated channel subfamily A member 5Homo sapiens (human)3.3
Amine oxidase [flavin-containing] BHomo sapiens (human)0.049
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)0.6967
Mitogen-activated protein kinase 10Homo sapiens (human)5.78
Mitogen-activated protein kinase 14Homo sapiens (human)5.78
Cytochrome P450 1B1Homo sapiens (human)0.011
Inositol hexakisphosphate kinase 2Homo sapiens (human)5.7
Potassium voltage-gated channel subfamily D member 3Homo sapiens (human)9.3

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB1
Chen, LC; Hsu, KC; Huang, HL; Huang, WJ; Lien, ST; Lin, TE; Ngo, ST; Pan, SL; Sung, TY; Tseng, HJ; Wu, YW; Yen, SC1

Other Studies

2 other study(ies) available for sorafenib and acacetin

ArticleYear
Navigating the kinome.
    Nature chemical biology, 2011, Volume: 7, Issue:4

    Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology

2011
Investigation of Selected Flavonoid Derivatives as Potent FLT3 Inhibitors for the Potential Treatment of Acute Myeloid Leukemia.
    Journal of natural products, 2021, 01-22, Volume: 84, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Flavonoids; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Mutation; Protein Kinase Inhibitors; Xenograft Model Antitumor Assays

2021